JUL 23, 2020 6:11 AM PDT

Prostate Cancer: To Treat or Not to Treat

WRITTEN BY: Tara Fernandez

After a prostate cancer diagnosis, urologists do not always initiate immediate clinical intervention. In those with low-risk prostate cancer, a “wait and see” approach is usually recommended — a strategy known as active surveillance. During this post-diagnostic monitoring period, the patient’s health care team keeps a close eye on their condition via regular testing. However, exactly which patients should go down the active surveillance track remains a grey zone.

Mieke Van Hemelrijck from King’s College London is a lead researcher and part of the GAP3 consortium, the world’s biggest active surveillance prostate cancer database. Van Hemelrijck and colleagues have recently developed a tool to gauge risk levels in prostate cancer patients, allowing them to make data-driven medical decisions.

"Current methods of deciding whether or not to recommend treatment are not reliable,” said Van Hemelrijck. 

“Our analysis shows that we should be able to produce a single global methodology, which will give accurate estimates of how aggressive these cancers are. These will feed directly into the treatment decision, and give men the reassurance they need to decide on treatment". The work was presented at the virtual European Association of Urology Congress.

Prostate cancers are detected with a prostate-specific antigen, or PSA, blood test, and most of the time, these tumors are considered low risk. In low-risk patients, the tumor is small, contained within the prostate, and is growing so slowly that it is extremely unlikely that it will become life-threatening. In these cases, treatment strategies are unnecessary, especially considering the side effects: impotence, leaking urine, and painful bowel movements. In some countries, up to 80 percent of men diagnosed with prostate cancer opt for active surveillance over treatment.

In a big leap forward, researchers of the GAP3 Consortium have developed the prostate cancer tool called a nomogram — a treatment calculator tool that provides advice on whether or not to pursue treatment. The researchers have created the world’s biggest database on active surveillance with data from over 14,000 patients. It includes information on age, size, tumor status, PSA levels, genetic factors, and the time spent on active surveillance.

"Not surprisingly, we have found that even accounting for these factors there was still differences in outcomes between participating centers. But this work has shown that it will be possible to produce a nomogram which can guide treatment,” said Van Hemelrijck. 

“Just as importantly, the work shows which additional factors need to be included in the nomogram in future to enable us to eliminate this variation and produce accurate estimates of tumor aggressiveness".

 

 

Source: European Association of Urology, EurekAlert.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 13, 2020
Cancer
Workers in Transportation Might be More at Risk for Cancer
JUL 13, 2020
Workers in Transportation Might be More at Risk for Cancer
Road transportation workers are essential employees in any country. They represent truck, bus, taxi, and other such driv ...
JUL 27, 2020
Cancer
Identifying Tumor Cells in the Blood with Artificial Intelligence
JUL 27, 2020
Identifying Tumor Cells in the Blood with Artificial Intelligence
Cancer diagnostics is an area of keen interest in the fight against cancer. Cancer often slips by routine checkups and v ...
AUG 04, 2020
Cardiology
Does Chronic Anxiety Affect Heart Health?
AUG 04, 2020
Does Chronic Anxiety Affect Heart Health?
Anxiety is something that is talked about far more often nowadays. In recent years, it has even been linked to a variety ...
SEP 03, 2020
Cell & Molecular Biology
Diagnosing Non-Celiac Gluten Sensitivity
SEP 03, 2020
Diagnosing Non-Celiac Gluten Sensitivity
Many clinicians once thought that only celiac disease caused gluten intolerance. But some people without it report gastr ...
SEP 28, 2020
Cancer
A New Transcriptomics Program in the Works Glioma Diagnosis
SEP 28, 2020
A New Transcriptomics Program in the Works Glioma Diagnosis
The future of medicine is “personalized healthcare.” However, testing remains a critical hurdle researcher&r ...
OCT 02, 2020
Clinical & Molecular DX
Detecting Dystonia in the Blink of an AI
OCT 02, 2020
Detecting Dystonia in the Blink of an AI
A team of scientists have created a diagnostic tool, powered by artificial intelligence (AI), that can pick up on the su ...
Loading Comments...